Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
Submitted by
admin
on October 13, 2017 - 9:34am
Source:
Fierce Pharma
News Tags:
Pfizer
FDA
Lyrica
generics
Lyrica CR
shingles
diabetic peripheral neuropathy
Headline:
With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
Do Not Allow Advertisers to Use My Personal information